Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study
Background: Treating inflammatory bowel disease (IBD) with antidepressants might be of utility to improve patient′s condition. The aim of this study was to assess the efficacy of Duloxetine on depression, anxiety, severity of symptoms, and quality of life (QOL) in IBD patients. Materials and Methods...
Main Authors: | Hamed Daghaghzadeh, Fateme Naji, Hamid Afshar, Mohammad Reza Sharbafchi, Awat Feizi, Mohsen Maroufi, Mahshid Tabatabaeeyan, Peyman Adibi, Hamid Tavakoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2015;volume=20;issue=6;spage=595;epage=601;aulast=Daghaghzadeh |
Similar Items
-
Investigation the effectiveness of duloxetine in quality of life and symptoms of patients with irritable bowel syndrome
by: Razieh Salehian, et al.
Published: (2021-01-01) -
Effects of venlafaxine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome
by: Mohammad Reza Sharbafchi, et al.
Published: (2020-01-01) -
Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life
by: Mahshid Tabatabaeian, et al.
Published: (2015-01-01) -
Duloxetine-induced Sleep Bruxism in Fibromyalgia Successfully Treated With Amitriptyline
by: Şule Şahin Onat, et al.
Published: (2015-10-01) -
Tumor growth activity of duloxetine in Ehrlich carcinoma in mice
by: Ed Carlos Rey Moura, et al.
Published: (2018-07-01)